ALEXANDER LEVERETT: Open Payments
NPI 1144900846 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,048 in 113 payments from 43 companies in 2025. Trend: 2023 $961 · 2024 $2,655 · 2025 $3,048
Food & beverage: $2,949Education: $99
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 7 | $362 |
| Merck Sharp & Dohme LLC | 11 | $263 |
| SOBI, INC | 3 | $260 |
| Novartis Pharmaceuticals Corporation | 10 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $123 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| Ipsen Biopharmaceuticals, Inc | 1 | $99 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Daiichi Sankyo Inc. | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $83 |
Products named: Yescarta, Vonjo, KEYTRUDA, KISQALI, SCEMBLIX, VERZENIO, BELEODAQ, LIBTAYO.
Industry payments across SC — which companies pay providers there.
